Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-03-11 08:19 am Purchase | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | FMR LLC | 4,506,467 12.749% | 2,856,964 (+173.20%) | View |
| 2024-02-14 3:04 pm Purchase | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | Cormorant Asset Management LP | 2,141,506 9.99% | 339,559 (+18.84%) | View |
| 2024-02-14 10:03 am Purchase | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | PRICE T ROWE ASSOCIATES INC | 1,626,982 7.6% | 116,021 (+7.68%) | View |
| 2024-02-14 06:03 am Sale | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | Point72 Asset Management L.P. | 825,000 3.8% | -425,000 (-34.00%) | View |
| 2024-02-13 4:07 pm Sale | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | HBM Healthcare Investments (Cayman) Ltd. | 0 0% | -1,345,009 (Position Closed) | View |
| 2024-02-13 09:55 am Sale | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | Prosight Management LP | 0 0% | -948,012 (Position Closed) | View |
| 2024-02-09 09:16 am Sale | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | FMR LLC | 1,649,503 7.694% | -297,813 (-15.29%) | View |
| 2024-01-30 11:23 am Purchase | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | Farallon Capital Partners L.P. | 2,205,990 9.99% | 788,073 (+55.58%) | View |
| 2024-01-29 5:01 pm Sale | 13D | LONGBOARD PHARMACEUTICALS INC LBPH | PFIZER INC PFE | 0 0% | -3,978,540 (Position Closed) | View |
| 2024-01-26 4:19 pm Sale | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | INTEGRATED CORE STRATEGIES (US) LLC | 6,610 0% | -981,102 (-99.33%) | View |
| 2024-01-12 5:00 pm Purchase | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | RA CAPITAL MANAGEMENT L.P. | 3,073,119 8.7% | 3,073,119 (New Position) | View |
| 2024-01-10 4:12 pm Unchanged | 13D | LONGBOARD PHARMACEUTICALS INC LBPH | PFIZER INC PFE | 3,978,540 11.26% | 0 (Unchanged) | View |
| 2023-11-13 09:02 am Sale | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | FMR LLC | 1,947,316 9.472% | -953,076 (-32.86%) | View |
| 2023-04-19 9:48 pm Purchase | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | Prosight Management LP | 948,012 4.9% | 948,012 (New Position) | View |
| 2023-03-27 4:27 pm Unchanged | 13D | LONGBOARD PHARMACEUTICALS INC LBPH | PFIZER INC PFE | 3,978,540 17.3% | 0 (Unchanged) | View |
| 2023-03-10 09:30 am Purchase | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | FMR LLC | 2,900,392 14.999% | 1,795,488 (+162.50%) | View |
| 2023-02-14 4:01 pm Purchase | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | HBM Healthcare Investments (Cayman) Ltd. | 1,345,009 9.99% | 17,579 (+1.32%) | View |
| 2023-02-14 3:05 pm Purchase | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | Cormorant Asset Management LP | 1,801,947 9.99% | 420,015 (+30.39%) | View |
| 2023-02-14 12:38 pm Sale | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | PRICE T ROWE ASSOCIATES INC | 1,510,961 11.1% | -513,655 (-25.37%) | View |
| 2023-02-13 8:33 pm Purchase | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | Point72 Asset Management L.P. | 1,250,000 6.5% | 1,250,000 (New Position) | View |